Groupe la Francaise decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 4.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 28,198 shares of the healthcare conglomerate’s stock after selling 1,285 shares during the period. Groupe la Francaise’s holdings in UnitedHealth Group were worth $14,528,000 at the end of the most recent reporting period.
Other hedge funds also recently added to or reduced their stakes in the company. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group during the 4th quarter worth $26,000. Bayforest Capital Ltd grew its holdings in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd grew its holdings in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 50 shares in the last quarter. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at about $42,000. Finally, Kapitalo Investimentos Ltda acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $41,000. 87.86% of the stock is owned by institutional investors and hedge funds.
UnitedHealth Group Stock Up 1.2%
UNH stock opened at $307.0980 on Friday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a market capitalization of $278.13 billion, a price-to-earnings ratio of 13.31, a price-to-earnings-growth ratio of 1.96 and a beta of 0.43. The firm’s 50-day moving average is $288.39 and its two-hundred day moving average is $389.57. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group’s payout ratio is 38.30%.
Insider Activity at UnitedHealth Group
In related news, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer directly owned 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.28% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
UNH has been the subject of several research reports. TD Securities reaffirmed a “hold” rating and issued a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Oppenheimer decreased their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Erste Group Bank lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. Robert W. Baird reissued an “underperform” rating and set a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Finally, TD Cowen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price for the company. in a research note on Monday, May 19th. Fifteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $365.38.
Read Our Latest Research Report on UNH
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Top Stocks Investing in 5G Technology
- MarketBeat Week in Review – 08/18 – 08/22
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Royal Caribbean Earnings Beat Fuels Strong 2025 Outlook
- 3 Warren Buffett Stocks to Buy Now
- Alphabet’s Breakout Potential: From Laggard to AI Leader
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.